Ardelyx Presents Additional Data at the 2024 Digestive Disease Week Conference on IBSRELA® (tenapanor), a First-In-Class Treatment for IBS-C in Adults PRESS RELEASE GlobeNewswire ...

In a new study on IBS patients, people on both low-carb and low-FODMAP diets experienced more symptom improvement than people on medication. Experts say there is no one-size-fits-all dietary ...

3. Medication In diarrhoea, some antidiarrheal medication, such as loperamide can be beneficial. Since IBS-M symptoms alternate between diarrhoea and constipation, it is important to be cautious ...

Lacy BE. Tenapanor treatment success for IBS-C symptoms increases with duration of therapy. Presented at: ACG Annual Scientific Meeting; Oct. 20-25, 2023; Vancouver, British Columbia (hybrid meeting).

Raymond James initiated coverage of Ardelyx Inc (NASDAQ: ARDX), noting the company's two early-stage launches underway for the same molecule with differentiated pricing: ...

DEAR DR. ROACH: I’m a young adult male who has been diagnosed with irritable bowel syndrome with constipation (IBS-C). Until this diagnosis, I had never even heard of the condition.

Poster #Tu1658, entitled “Efficacy of Tenapanor in Patients with Irritable Bowel Syndrome with Constipation (IBS-C): A Post Hoc Analysis of Patients with and Without Prior Use of Other IBS-C ...

Poster #Tu1658, entitled “Efficacy of Tenapanor in Patients with Irritable Bowel Syndrome with Constipation (IBS-C): A Post Hoc Analysis of Patients with and Without Prior Use of Other IBS-C ...